The report provides a detailed analysis essential for establishing a cephapirin production plant. It encompasses all critical aspects necessary for cephapirin production, including the cost of cephapirin production, cephapirin plant cost, cephapirin production costs, and the overall cephapirin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a cephapirin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Cephapirin is an antibiotic compound that finds important applications mainly in the veterinary and pharmaceutical industry. It is primarily used as an antibacterial agent for treating bacterial infections in animals, especially in dairy cattle. It finds its main application in the management of mastitis, which is a common udder infection in cows, where it helps control harmful bacteria and supports animal health. It is also used in the management of endometritis to improve reproductive health in animals, particularly cows. It is also used as a drug in the treatment of respiratory tract infections such as pneumonia, bronchitis, pharyngitis, sinusitis, and otitis media in humans. Moreover, it is often used for preoperative prophylaxis before certain surgical procedures to reduce the risk of surgical site infections. It is also sometimes used in the treatment of skin and soft tissue infections, as well as urinary tract infections and gastrointestinal issues like enteritis and peritonitis.
The market for cephapirin is predominantly driven by its demand as an antibacterial drug in various medical applications against susceptible bacteria. Its application as a medication for intramammary treatment of mastitis and intrauterine treatment of endometritis in cattle significantly drives its demand in the veterinary and animal healthcare industries. Its usage in veterinary medicine for preventing and treating other susceptible infections in animals caused by Gram-positive organisms largely contributes to its demand in the animal health and livestock care industry.
Its usage as an antibacterial agent to treat soft tissue infections caused by streptococci or methicillin-sensitive Staphylococcus aureus, peritonitis, and urinary tract infections further supports its demand in the pharmaceutical industry. Its demand as a valuable antibiotic in veterinary treatment and agricultural practices also drives its market growth. Additionally, industrial cephapirin procurement depends on multiple factors such as the cost and availability of active ingredients, adherence to veterinary drug regulations, and product quality standards. Developments in sterile formulation techniques, supplier dependability, sustainable production approaches, and the efficiency of cold chain logistics also play a major role in influencing industrial procurement for cephapirin globally.
Raw Material for Cephapirin Production
According to the cephapirin production plant project report, the major raw materials for cephapirin production include 7-aminocephalosporanic acid, 4-chloropyridine, mercaptoacetic acid, and phosphorus pentachloride; 7-aminocephalosporanic acid, bromoacetyl bromide, and 4-mercaptopyridine.
Production Processes of Cephapirin
The extensive cephapirin production cost report consists of the following industrial production processes:
- Production via Chemical Synthesis: The production process of cephapirin begins with the acylation of 7-aminocephalosporanic acid using 4-pyridylthioacetic acid chloride. As the main step, 4-pyridylthioacetic acid chloride is prepared by first reacting 4-chloropyridine with mercaptoacetic acid in the presence of a base to form 4-pyridylthioacetic acid. Then, this acid is converted into its acid chloride form using phosphorus pentachloride. The complete process results in the formation of cephapirin as the final product.
- Production via Acylation: Alternatively, cephapirin can also be synthesised by first acylating 7-aminocephalosporanic acid with bromoacetyl bromide to form a bromoacetyl intermediate. Then, the obtained intermediate is reacted with 4-mercaptopyridine in the presence of triethylamine to form cephapirin as the final compound.
Cephapirin is a semisynthetic, first-generation cephalosporin antibiotic with broad-spectrum bactericidal activity against both Gram-positive and Gram-negative organisms. It appears as a white to off-white crystalline solid. The molecular formula of the compound is C17H17N3O6S2, and its molecular weight is 423.46 g/mol. It is generally marketed under the trade name Cefadyl. It has a density of approximately 1.40 g/cm³, and the compound decomposes at its melting point, which is above 135 degree Celsius. It is slightly soluble in dimethyl sulfoxide (DMSO) at up to 10 mg/mL and in dimethylformamide (DMF) at approximately 5 mg/mL, but has limited solubility in water. The boiling point of the compound is around 783.9 degree Celsius. It is recommended to store the compound at −20 degree Celsius under an inert atmosphere to maintain its stability. The compound is classified as a suspected carcinogen and may cause allergy or asthma symptoms if inhaled, as well as allergic skin reactions upon contact. It is recommended to wear protective clothing, gloves, and safety glasses while handling the substance. Extended exposure to this compound may lead to adverse health effects, including jaundice.